CEBPA and acute myeloid leukemia: Then, other AML clinical drugs, such as cytarabine and flavopiridol, were used to test their sensitivity in MV-4-11 and MOLM-13 cells overexpressing C/EBPα-p42, p30 and shCEBPA (Supplementary Fig. 10).